For the year ending 2025-12-31, TEVJF made $17,258M in revenue. $1,410M in net income. Net profit margin of 8.17%.
| Income Statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Net revenues | 17,258 | 16,544 | 15,846 | 14,925 |
| Cost of sales | 8,320 | 8,481 | 8,200 | 7,952 |
| Gross profit | 8,938 | 8,064 | 7,645 | 6,973 |
| Research and development expenses, net | 1,013 | 998 | 953 | 838 |
| Selling and marketing expenses | 2,686 | 2,541 | 2,336 | 2,265 |
| General and administrative expenses | 1,287 | 1,161 | 1,162 | 1,180 |
| Intangible assets impairments | 259 | 251 | 350 | 355 |
| Goodwill impairment | 0 | 1,280 | 700 | 2,045 |
| Other asset impairments, restructuring and other items | 1,050 | 1,388 | 718 | 414 |
| Legal settlements and loss contingencies | 467 | 761 | 1,043 | 2,082 |
| Other loss (income) | -18 | 14 | 49 | 107 |
| Operating income (loss) | 2,157 | -303 | 433 | -2,099 |
| Financial expenses net | -934 | -981 | -1,057 | -966 |
| Income (loss) before income taxes | 1,223 | -1,284 | -624 | -3,065 |
| Adjustments to valuation allowances on deferred tax assets-Revenue Commissioners Ireland | 40 | - | - | - |
| Other (amount)-Revenue Commissioners Ireland | -4 | - | - | - |
| Statutory tax rate difference (amount)-Malta Tax Authority | 34 | - | - | - |
| Reduced rate due to imputation system (amount)-Malta Tax Authority | 89 | - | - | - |
| Other (amount)-Malta Tax Authority | 6 | - | - | - |
| Adjustments to valuation allowances on deferred tax assets-Tax And Customs Administration Netherlands | 138 | - | - | - |
| Other (amount)-Tax And Customs Administration Netherlands | -1 | - | - | - |
| Statutory tax rate difference (amount)-Swiss Federal Tax Administration FTA | -162 | - | - | - |
| Adjustments to valuation allowances on deferred tax assets-Swiss Federal Tax Administration FTA | -33 | - | - | - |
| Other (amount)-Swiss Federal Tax Administration FTA | 4 | - | - | - |
| Changes in unrecognized tax benefits (amount)-Other Countries Tax Authority | 60 | - | - | - |
| Adjustments to valuation allowances on deferred tax assets-Other Countries Tax Authority | 187 | - | - | - |
| Income taxes (benefit) | -180 | 676 | -7 | -638 |
| Share in (profits) losses of associated companies net | 15 | 1 | 2 | 21 |
| Net income (loss) | 1,418 | -1,959 | -615 | -2,406 |
| Net income (loss) attributable to redeemable and non-redeemable non-controlling interests | 7 | -320 | -56 | -53 |
| Net income (loss) attributable to teva | 1,410 | -1,639 | -559 | -2,353 |
| Earnings per share, basic | 1.23 | -1.45 | -0.5 | -2.12 |
| Earnings per share, diluted | 1.21 | -1.45 | -0.5 | -2.12 |
| Weighted average number of shares outstanding, basic | 1,145,000,000 | 1,131,000,000 | 1,119,000,000 | 1,110,000,000 |
| Weighted average number of shares outstanding, diluted | 1,163,000,000 | 1,131,000,000 | 1,119,000,000 | 1,110,000,000 |
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVJF)
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVJF)